¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"chronic active inflammation"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • active marrow
    Ȱ¼º°ñ¼ö
  • active material
    Ȱ¼º¹°Áú, Ȱ¼ºÀç
  • active movement
    ´Éµ¿¿îµ¿
  • active negativism
    Àû±Ø°ÅºÎÁõ
  • active oxygen
    Ȱµ¿»ê¼Ò, Ȱ¼º»ê¼Ò
  • active phase
    Ȱ¼º±â
  • active placebo
    Ȱ¼º¼ÓÀÓ¾à
  • active prosthesis
    Ȱµ¿ÀÇÁö, ´Éµ¿ÀÇÁö
  • active shielding
    ´Éµ¿Â÷Æó
  • active shimming
    ´Éµ¿º¸Á¤
  • active site
    Ȱ¼ººÎÀ§
  • active transport
    ´Éµ¿¿î¹Ý
  • active treatment
    Àû±ØÄ¡·á
  • active tuberculosis
    Ȱµ¿°áÇÙ
  • MR active nuclei
    ÀÚ±â°ø¸íȰ¼ºÇÙ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • active transport
    ´Éµ¿¿î¹Ý
  • active treatment
    Àû±ØÄ¡·á
  • active tuberculosis
    Ȱµ¿°áÇÙ
  • active gradient shielding
    ´Éµ¿±â¿ï±âÂ÷Æó, ´Éµ¿°æ»çÂ÷Æó
  • active incorporative mode
    Àû±ØÇÔÀÔ¾ç½Ä
  • artificial active immunity
    Àΰø´Éµ¿¸é¿ª
  • surface-active disinfectant
    Ç¥¸éȰ¼º¼Òµ¶Á¦, °è¸éȰ¼º¼Òµ¶Á¦
  • metabolically active stone
    ´ë»çȰ¼ºµ¹
  • MR active nuclei
    ÀÚ±â°ø¸íȰ¼ºÇÙ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • inflammation,necrotizing
    ±«»ç¼º(ÎÕÞÝàõ)
  • inflammation,plasma proteases
    Ç÷Àå ÇÁ·ÎÅ×¾ÆÁ¦(úìíì ¡­)
  • inflammation,vascular flow and caliber
    Ç÷°üÇ÷·ù(úìηúì×µ)¿Í±¸°æ(Ï¢ÌÓ)
  • inflammation,vascular permeability
    Åõ°ú¼º(úìη ÷âΦàõ)
  • interstitial inflammation
    °£Áú¼º ¿°(Áõ).(¡­ æú(ñø))
  • interstitital inflammation
    °£Áú¼º ¿°Áõ(¡­ æúñø)
  • mechanical inflammation =MI
    ±â°èÀû ¿°Áõ(¡­æúñø).
  • membranous inflammation
    ¸·¼º¿°Áõ(¡­àõæúñø)
  • metastatic inflammation
    ÀüÀ̼º ¿°Áõ(¡­æúñø).
  • necrotic inflammation =necrotizing i.
    ±«»ç¼º ¿°(ÎÕÞÝàõæú).(º´¸®) ±«»ç¼º ¿°Áõ.
  • necrotic inflammation =necrotizing i.
    ±«»ç¼º ¿°(ÎÕÞÝàõæú). ±«»ç¼º ¿°Áõ( ¡­ æúñø)
  • necrotizing inflammation
    ±«»ç¼º ¿°Áõ(¡­æúñø)
  • obliterative inflammation
    Æó»ö¼º ¿°Áõ.
  • obliterative inflammation
    Æó»ö¼º ¿°Áõ(¡­æúñø)
  • odontogenic inflammation of jaw
    Ä¡¼º ¾Ç¿°(öÍàõäÉæú).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
CAAH chronic active autoimmune hepatitis
CAC/CIC chronic active/inactive cirrhosis
CALD chronic active liver disease
CALH chronic active lupoid hepatitis
JVP [POMD P 49 - 52]
  1) Jugular Vein Pressure
  2) Jugular Venous Pulse
...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
TANs Tonically Active Neurons
TAM Total active motion
VIP Vaso-active intestinal polypeptide
ARFC active rosette forming cell
AI active ingredient
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • chronic disease
    ¸¸¼º Áúȯ
    º´ÀÇ °æ°úÀÇ Àå´Ü¿¡ ÀÇÇÑ ºÐ·ù. º¸Åë 6°³¿ù ȤÀº l³â ÀÌ»ó °è¼ÓµÇ´Â ÁúȯÀ» ¸»Çϸç, ±Þ¼º Áúȯ°ú ´ëÀÀÇÑ´Ù. ±× Áõ¼¼°¡ ¿Ï¸¸ÇÏ°Ô ³ªÅ¸³ª Àå±â°£ Áö¼ÓÇϹǷΠ¸¸¼º Áõ»óÀ̶ó Çϸç, À̰͵µ ±Þ¼º Áúȯ¿¡¼­ÀÇ ±Þ¼º Áõ»ó¿¡ ´ëÀÀÇÏ´Â ¸»ÀÌ´Ù. ´ëÇ¥ÀûÀÎ ¸¸¼º ÁúÇÑÀ¸·Î´Â °áÇÙ, ³ªº´, ¸Åµ¶ µîÀÌ ÀÖ°í, ±Þ¼º Áúȯ¿¡¼­ ÀÌÇàÇÏ´Â °Íµµ ¸¹´Ù. ´Ü¼øÈ÷ ¾ËÄÚ¿Ã Áßµ¶À̳ª °üÀý ·ù¸ÓƼÁò µîÀÇ °æ¿ì´Â ¸¸¼ºÀ¸·Î º¸´Â °æ¿ì°¡ ¸¹´Ù.
  • chronic empyema
    ¸¸¼º ³óÈä
  • chronic endemic dental fluorosis
    ¸¸¼º À¯Ç༺ Ä¡¾Æ ºÒ¼Ò Ä§ÂøÁõ, ¸¸¼º dzÅ伺 Ä¡¾Æ ºÒ¼Ò Ä§ÂøÁõ
  • chronic erythematous atrophic candidosis
    ¸¸¼º È«¹Ý¼º À§Ã༺ ĵµð´ÙÁõ
  • chronic exposure
    ¸¸¼º ³ëÃâ
  • chronic factitious disorder with physical symptom
    ¸¸¼º ÀΰøÀû Àå¾Ö ½ÅüÀû
  • chronic fatigue syndrome
    ¸¸¼º ÇÇ·Î ÁõÈıº
    ½±°Ô ÇǰïÇϰí ÁöÄ¡¸ç ¸öÀÌ ³ª¸¥ÇØÁö´Â µîÀÇ ÇÇ·Î Áõ¼¼°¡ 6°³¿ù ÀÌ»ó ¸¸¼ºÀûÀ¸·Î Áö¼ÓÇÏ´Â Áõ»ó. È®½ÇÇÑ ¿øÀÎÀº ¹àÇôÁ® ÀÖÁö ¾Ê°í, ¹ÙÀÌ·¯½º °¨¿°ÀÌ ±× ¿øÀÎÀÇ Çϳª·Î ÃßÁ¤µÈ´Ù. Æò¼Ò °Ç°­ÇÑ »ç¶÷¿¡°Ô¼­ °¨±â³ª ¸ö»ì ±â¿îÀÌ ÀÖ´Ù°¡ ÀÌ·± ÇǷΰ¡ ³ªÅ¸³­´Ù. ´ëü·Î Ưº°ÇÑ Ä¡·á°¡ ÇÊ¿ä¾øÀÌ ÀúÀý·Î Ä¡À¯µÇ³ª ÇǷθ¦ ´À³¢°Ô ÇÏ´Â ´Ù¸¥ Áúº´ÀÇ À¯¹«¸¦ È®ÀÎÇÏ´Â °ÍÀÌ Áß¿äÇÏ´Ù. ƯÈ÷ ½ºÆ®·¹½º, ¿ì¿ïÁõ, ºÒ¾ÈÀå¾Ö µî°ú °°Àº Á¤½ÅÀû ¹®Á¦°¡ ¾à 50 %¸¦ Â÷ÁöÇϸç, ½ÅüÀû ÁúȯÀ¸·Î´Â ´ç´¢º´, °©»ó¼± Áúȯ, ¸¸¼º È£Èí±â Áúȯ, ºóÇ÷, °áÇÙ, °£¿°, ½ÅÀå ÁúȯÀ̳ª ¾Ï µî¿¡ ÀÇÇØ¼­µµ ¸¸¼ºÀû ÇǷΰ¨À» ´À³¥ ¼ö ÀÖ´Ù. ÀÌ¿Í °°Àº ÁúȯÀÌ ¾ø´Â °ÍÀÌ ÆÇ¸íµÇ¸é ¸¸¼º ÇÇ·Î ÁõÈıºÀ¸·Î Áø´ÜÇÒ ¼ö ÀÖ´Ù.
  • chronic flying sickness
    ¸¸¼º Ç×°øº´
    Àå±â°£ Ç×°ø±â¿¡ ž½ÂÇÏ´Â »ç¶÷¿¡°Ô ÀϾ´Â Á÷¾÷º´. Ç×°ø±âÀÇ ²÷ÀÓ¾ø´Â µ¿¿ä, ¼±È¸, °¡¼Óµµ, °í°ø ºñÇàÀ¸·ÎºÎÅÍ ¿À´Â »ê¼ÒÀÇ ºÎÁ·, ±â¾ÐÀÌ ³·Àº °í°øÀ» ºñÇàÇϰųª Àú¾Ð½Ç¿¡¼­ ÀÛ¾÷À» ÇÏ´Â °æ¿ì, ±×°ÍÀ¸·Î ±Þ¼º ÁúȯÀÌ ÀϾÁö ¾Ê´Â Á¤µµÀÇ È¯°æÀÌ Àå±â°£¿¡ °ÉÃļ­ µÇÇ®ÀÌµÉ ¶§ ¹ß»ýÇϱ⠽±´Ù. Áõ¼¼´Â Ãʱ⿡ ´«ÀÇ ÇÇ·Î, µÎÅë, ÇǷΰ¨ µîÀÇ ÀÚ°¢ Áõ¼¼°¡ ÀϾ°í, ÀÌ¿Í °°Àº ´Ü°è°¡ Áö³ª¸é ÃÊÁ¶°¨, ½Å°æÁú, ºÒ¸éÁõ, ±â¾ï·Â, ÁýÁß·ÂÀÇ °¨Åð¿Í ÇÔ²² ±¸Åä, Çö±âÁõ, ¼ÒÈ­ºÒ·® µîÀÌ ÀϾ´Ù. À̰ÍÀº °í°ø ºñÇàÀ̳ª, ¼Óµµ°¡ ºü¸£°í ¼±È¸°¡ ½ÉÇÑ ÀüÅõ±â¸¦ Á¶Á¾ÇÏ´Â ÀüÅõ Á¶Á¾»ç¿¡°Ô ¹ß»ýµÇ´Â °æ¿ì°¡ ¸¹´Ù.
  • chronic gingivitis
    ¸¸¼º Ä¡Àº¿°
    1. º¯¿¬ Ä¡ÀºÀÇ ºÎÁ¾, ÃâÇ÷À» º¸ÀδÙ. È­³ó¼ºÀ̸ç, Ä¡ÀºÀÇ Á¡¸ôÀÌ ¼Ò½ÇµÈ´Ù. ±¹¼ÒÀûÀÌ ¿äÀÎÀ¸·Î´Â ¹Ì»ý¹°, À½½Ä¹° ¾ÐÀÔ, ºÎÀûÀýÇÑ º¸Á¸ óġ³ª º¸Ã¶¹°, ±¸È£Èí, Ä¡¾ÆÀÇ À§Ä¡ ÀÌ»ó, È­Çй°Áú ȤÀº ¾à¹° º¹¿ëÀÌ ÀÖÀ¸¸ç, Àü½ÅÀûÀÎ ¿äÀÎÀ¸·Î´Â ¿µ¾ç Àå¾Ö, ¾à¸® ÀÛ¿ë, ÀÓ½Å, ´ç´¢, ¾Ë·¯Áö, À¯Àü, Á¤½Å Áúȯ µîÀÌ ÀÖ´Ù. 2. Ä¡ÀºÀÌ Àü¹ÝÀûÀ¸·Î â¹éÇÏ°í ¼¶À¯¼º ¿Ü°üÀ» °¡Áö´Â ¿­±¸ ¸é°ú Ä¡°£ À¯µÎÀÇ ¿°ÁõÀÌ´Ù. Ä¡Àº À¯µÎÀÇ ¼Ò½Ç°ú °°Àº Ä¡ÀºÀÇ ¿ÜÇü º¯È­µµ ÀϾ ¼ö ÀÖ´Ù. À̰ÍÀº ¼ö³â°£ÀÇ ¿°Áõ¼º Ä¡Àº ¼Õ»ó¿¡ ´ëÇÑ ¸¸¼ºÀû ¼øÈ¯Àû º¹±¸ ¹ÝÀÀÀ̸ç Ä¡ÁÖ¿°ÀÇ Æ¯Â¡°ú ¿¬°üµÉ ¶§°¡ ÀÖ´Ù.
  • chronic granulocytic leukemia
    ¸¸¼º °ú¸³±¸ ¹éÇ÷º´, ¸¸¼º °ú¸³±¸¼º ¹éÇ÷º´
  • chronic headache
    ¸¸¼º µÎÅë
  • chronic hemorrhage
    ¸¸¼º ÃâÇ÷
  • chronic hepatitis B
    ¸¸¼º BÇü °£¿°
  • chronic hyperplastic gingivitis
    ¸¸¼º Áõ½Ä¼º Ä¡Àº¿°
  • chronic hypertrophic pharyngitis
    ¸¸¼º ºñÈÄ Àεο°, ¸¸¼º ºñÈļº Àεο°
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
active site <chemistry> A specific region of an enzyme where a substrate binds and catalysis takes place (binding site).
(06 May 1997)
active splint A splint utilizing springs or elastic bands that aids in movements initiated by the patient by controlling the plane and range of motion.
Synonym: active splint, functional splint.
(05 Mar 2000)
active succinate The condensation product of succinic acid and CoA; one of the intermediates of the tricarboxylic acid cycle and a precursor in the synthesis of haem.
Synonym: active succinate, succinyl-CoA.
(05 Mar 2000)
active sulfate 3'-phosphoadenosine 5'-phosphosulfate;an intermediate in the formation of urinary ethereal sulfates, notable for containing a "high energy" sulfate bond; the 3'-OH of adenosine is replaced by -OPO3H2, the 5'-OH by -OP(O2H)-OSO3H.
Synonym: active sulfate.
Acronym: PAPS
(05 Mar 2000)
active transport <biochemistry, chemistry> Transport of ions, nutrients or other molecules into a cell against a concentration gradient, this requires the expenditure of energy through ATP hydrolysis.
(06 May 1997)
active treatment A therapeutic substance or course intended to ameliorate the basic disease problem, as opposed to supportive or palliative treatment.
Compare: causal treatment.
(05 Mar 2000)
active vasoconstriction Reduced caliber of a vessel caused by increased tonus in the smooth muscle in its walls.
(05 Mar 2000)
active vasodilation Vasodilation caused by decrease in tonus of smooth muscle in the wall of a vessel.
(05 Mar 2000)
artificial active immunity See: acquired immunity.
(05 Mar 2000)
biological transport, active The movement of materials across cell membranes and epithelial layers against an electrochemical gradient, requiring the expenditure of metabolic energy.
(12 Dec 1998)
specific active immunity See: acquired immunity.
(05 Mar 2000)
surface-active Indicating the property of certain agents of altering the physicochemical nature of surfaces and interfaces, bringing about lowering of interfacial tension; they usually possess both lipophilic and hydrophilic groups.
See: surfactant.
(05 Mar 2000)
surface-active agent Agents that modify interfacial tension of water; usually substances that have one lipophilic and one hydrophilic group in the molecule; includes soaps, detergents, emulsifiers, dispersing and wetting agents, and several groups of antiseptics.
(12 Dec 1998)
surface active compound <biochemistry> Usually, in biological systems, means a detergent like molecule that is amphipathic and that will bind to the plasma membrane or to a surface with which cells come in contact, altering its properties from hydrophobic to hydrophilic or vice versa.
(18 Nov 1997)
immunity, active Resistance to a disease agent resulting from the production of specific antibodies by the host, either after exposure to the disease or after vaccination.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á